2da - Maybe I'm too optimistic but things feel different this time around. Harvey's got much less swagger (after being whacked between the eyes by the FDA) and now seems open to options other than building the next Celgene. The fact that Denner is looking over management's shoulder is a good thing. ARIA is no longer HB's private sandbox. Let's hope he (Denner) sticks around.
Market Data 
Markets 
AI
